PRCT
PROCEPT BioRobotics Corp
Next earnings Aug 4, 2026 (after close) · consensus $-0.47 EPS, $94.9M rev
Last earnings -5.7% on 2026-04-29
$22.56
▲ +4.98%$22.56▼ -60.36%
over 1Y
L $20.60EODHDH $60.06
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+5.0%
1W+5.0%
1M-14.7%
3M-14.4%
YTD-26.7%
1Y-60.4%
Hold
Conviction
Horizon
Medium (3–12mo)
Street · 21 analysts
Buy
Revenue grew 37.2% YoY; but unprofitable (net margin -31.0%).
Revenue (FY2025) $308M · FY2025
PROCEPT BioRobotics Corp shows $308M in FY2025 revenue (+37.2% YoY), a -31.0% net margin, and -26.1% ROE.
Financials · annual, by fiscal year
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $34.5M | $75.0M | $136M | $224M | $308M |
| Gross profit | $15.9M | $37.1M | $71.0M | $137M | $196M |
| Operating income | -$54.2M | -$80.7M | -$109M | -$96.6M | -$104M |
| Net income | -$59.9M | -$87.2M | -$106M | -$91.4M | -$95.6M |
| Diluted EPS | -$3.63 | -$1.96 | -$2.24 | -$1.75 | -$1.72 |
| Net margin | -173.6% | -116.2% | -77.8% | -40.7% | -31.0% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Key statistics
Valuation
Enterprise value$1.04B
EV / EBITDA—
EV / Sales3.4
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield-7.5%
FCF yield-4.6%
Quality & risk
ROIC (est.)-19.7%
Free cash flow-$58.3M
Total debt$51.6M
Net cash$235M
Altman Z-Score4.44 safe
Piotroski F-Score3/9
Capital returns
Buyback yield—
Dividend yield (est.)—
Shareholder yield—
Shares Δ YoY+2.9%
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Disclosure timeline
SEC · 8-Ks + reportsSome governance/structural items recently, but no outright red flags.
Recent filings
all on EDGAR ↗4Period ending 2026-06-092026-06-10open ↗4Period ending 2026-06-092026-06-10open ↗4Period ending 2026-06-092026-06-10open ↗4Period ending 2026-06-092026-06-10open ↗4Period ending 2026-06-092026-06-10open ↗4Period ending 2026-06-092026-06-10open ↗4Period ending 2026-06-092026-06-10open ↗4Period ending 2026-06-092026-06-10open ↗8-KPeriod ending 2026-06-092026-06-10open ↗4Period ending 2026-06-082026-06-10open ↗4Period ending 2026-06-082026-06-10open ↗4Period ending 2026-06-082026-06-10open ↗
Frequently asked
- Is PROCEPT BioRobotics Corp (PRCT) a buy?
- PRCT currently carries a Hold rating with 2/5 conviction, derived from its latest SEC filings. Revenue grew 37.2% YoY; but unprofitable (net margin -31.0%).
- What is PROCEPT BioRobotics Corp's quality score?
- PRCT scores 49.74509803921568/100 (grade D) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.
Sources: SEC EDGAR (CIK 0001588978, latest 10-Q filed 2026-04-30) · EODHD · as of 6/26/2026, 6:07:16 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.